Moolec Science (MLEC) Change in Receivables (2023 - 2024)
Moolec Science's (MLEC) quarterly Change in Receivables came in at $1.9 million in Q4 2024, up 577.48% year-on-year from $284849.0 in Q1 2024, and up 3423.76% quarter-over-quarter from -$58061.0 in Q3 2024.
Moolec Science (MLEC) Change in Receivables (2023 - 2024) Analysis & Trends
Moolec Science has disclosed Change in Receivables across 2 years of filings, most recently posting $1.9 million for Q4 2024.
- Change in Receivables for Q4 2024 came in at $1.9 million, up 577.48% year-over-year; the trailing twelve-month figure through Dec 2024 was $1.9 million (up 577.48% YoY), and the FY2025 annual result was $26.0 million, up 5422.83% from the prior year.
- Change in Receivables came in at $1.9 million for Q4 2024 at Moolec Science, up from -$58061.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $1.9 million in Q4 2024 to a low of -$6.1 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -4.08 Mn |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1.93 Mn |
| Dec 31, 2024 | 1.93 Mn |
| Sep 30, 2024 | -58,061.00 |
| Sep 30, 2024 | -58,061.00 |
| Jun 30, 2024 | -6.13 Mn |
| Jun 30, 2024 | -6.13 Mn |
| Mar 31, 2024 | 548,336.00 |
| Mar 31, 2024 | 548,336.00 |
| Dec 31, 2023 | 284,849.00 |
| Dec 31, 2023 | 284,849.00 |
| Sep 30, 2023 | -146,394.00 |
| Sep 30, 2023 | -146,394.00 |
| Jun 30, 2023 | 361,097.00 |
| Jun 30, 2023 | 361,097.00 |
| Mar 31, 2023 | 316,972.00 |
| Mar 31, 2023 | 316,972.00 |